Clinical Trial

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

Study acronym: MAGraine2
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-03-24; most recent amendment 2026-01-21.
Status change: Not Yet Recruiting → Recruiting 2026-01-21
Trial Details
NCT Number NCT06904287
Lead Sponsor Wake Forest University Health Sciences
Conditions Migraine
Enrollment 100 participants
Start Date 2025-12-16
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-22